Performance of a prognostic 31-gene expression profile test in patients with node-negative cutaneous melanoma.

Pedram Gerami,Kyle R. Covington,Olga Zolochevska,Ann P. Quick,Robert W. Cook,Jeffrey D. Wayne

Performance of a prognostic 31-gene expression profile test in patients with node-negative cutaneous melanoma.

2020

Pedram Gerami
Kyle R. Covington
Olga Zolochevska
Ann P. Quick
Robert W. Cook
Jeffrey D. Wayne

e22071Background: The National Comprehensive Cancer Network guidelines recommend considering sentinel lymph node biopsy (SLNB) for cutaneous melanoma (CM) patients with a 5-10% risk of SLN positivi...

Keywords:

Oncology
Internal medicine
cutaneous melanoma
node negative
in patient
Pathology
Gene expression
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations